Concise Commentary: Whether and When to Resume Anticoagulation After Gastrointestinal Bleeding
Sign Up to like & getrecommendations! Published in 2020 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-020-06323-1
Abstract: The timing of resuming oral anticoagulants after gastrointestinal bleeding (GIB) is still controversial in clinical practice due to the lack of evidence-based guideline recommendations. In this issue of the Digestive Diseases and Sciences, Tapaskar et… read more here.
Keywords: doac; gib; oral anticoagulants; resumption ... See more keywords
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology Reports"
DOI: 10.1007/s11912-022-01241-z
Abstract: The reintroduction of immune checkpoint inhibitors (ICIs) after disease progression (rechallenge) or immune-related adverse events (irAEs) recovering (resumption) raises questions in terms of efficacy and safety. Here, we reviewed literature data about ICIs rechallenge/resumption in… read more here.
Keywords: rechallenge resumption; checkpoint inhibitor; resumption; immune checkpoint ... See more keywords
Remarkable corrosion resumption of archaeological bronzes, induced by the oxidation of ternary Cu-Sn-S phases in atmosphere, after long-term burial with sulfides
Sign Up to like & getrecommendations! Published in 2020 at "Corrosion Science"
DOI: 10.1016/j.corsci.2020.108865
Abstract: Abstract A drastic alteration resumption observed on archaeological bronze objects was investigated, characterized by crystals growing under the surface of the objects, inducing cracks, desquamation and detachment of patina scales. Analyses shown that artefacts were… read more here.
Keywords: remarkable corrosion; archaeological bronzes; resumption archaeological; corrosion ... See more keywords
SGK1 is essential for meiotic resumption in mammalian oocytes.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of cell biology"
DOI: 10.1016/j.ejcb.2022.151210
Abstract: In mammalian females, oocytes are stored in the ovary and meiosis is arrested at the diplotene stage of prophase I. When females reach puberty oocytes are selectively recruited in cycles to grow, overcome the meiotic… read more here.
Keywords: sgk1 essential; essential meiotic; resumption; meiotic resumption ... See more keywords
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2020.100615
Abstract: Highlights • Chemotherapy resumption after convalescence from COVID-19 is safe and feasible.• No guidelines exist for resumption of chemotherapy in patients with COVID-19.• Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently. read more here.
Keywords: chemotherapy; ovarian cancer; resumption ovarian; resumption ... See more keywords
Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic Oncology"
DOI: 10.1016/s0090-8258(21)00874-x
Abstract: Objectives: The purpose of this study was to identify criteria for safe resumption of assisted reproductive technologies (ART) in women diagnosed with atypical endometrial hyperplasia (AH) or endometrial cancer (EC) during infertility evaluation and managed… read more here.
Keywords: sample; treatment; group; resumption assisted ... See more keywords
Resumption of Antiplatelet Therapy after Major Bleeding
Sign Up to like & getrecommendations! Published in 2022 at "Thrombosis and Haemostasis"
DOI: 10.1055/s-0042-1750419
Abstract: Abstract Major bleeding is a common threat in patients requiring antiplatelet therapy. Timing and intensity with regard to resumption of antiplatelet therapy represent a major challenge in clinical practice. Knowledge of the patient's bleeding risk,… read more here.
Keywords: major bleeding; resumption; risk; antiplatelet therapy ... See more keywords
Triggers of treatment interruption and resumption among individuals with type 2 diabetes: a narrative cross-sectional qualitative study
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Qualitative Studies on Health and Well-being"
DOI: 10.1080/17482631.2025.2496181
Abstract: ABSTRACT Purpose Treatment interruption and resumption are common among people with type 2 diabetes mellitus (T2D), but the triggers of resumption, according to the reasons for interruption, remain underexplored. This study examined patterns of treatment… read more here.
Keywords: treatment; treatment interruption; resumption; interruption resumption ... See more keywords
Resumption of anticoagulation therapy among Non-Valvular Atrial Fibrillation (NVAF) patients with prior intracranial haemorrhage
Sign Up to like & getrecommendations! Published in 2024 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehae666.594
Abstract: Resumption of anticoagulation therapy (OAC) in patients with non-valvular atrial fibrillation (NVAF) suffering from intracranial haemorrhage (ICH) is challenging in clinical practice. The aim of this study was to evaluate impact of resumption of OAC… read more here.
Keywords: vka; ashr; doac; risk ... See more keywords
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study
Sign Up to like & getrecommendations! Published in 2018 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehx598
Abstract: Aims We examined the risks of all‐cause mortality, stroke, major bleeding, and recurrent traumatic injury associated with resumption of vitamin K antagonists (VKAs) and non‐VKAs oral anticoagulants (NOACs) following traumatic injury in atrial fibrillation (AF)… read more here.
Keywords: hazard; atrial fibrillation; resumption; following traumatic ... See more keywords
Timing of resumption of immune checkpoint inhibitor therapy after successful control of immune-related adverse events in seven advanced non-small cell lung cancer patients
Sign Up to like & getrecommendations! Published in 2020 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000957
Abstract: Among advanced non-small cell lung cancer (NSCLC) patients in whom grade 2/3 immune-related adverse events (irAEs) that had developed during the initial immune checkpoint inhibitor (ICI) therapy had been successfully controlled, we experienced three patients… read more here.
Keywords: therapy; ici therapy; control; resumption ... See more keywords